Evaluation of angiogenesis in cervical cancer using CD34 as a biomarker and its correlation with pathoanatomical features

Abstract

Lung cancer is the most common cause of cancer-related death worldwide and unfortunately up to 80% of patients amongst newly diagnosed are inoperable therefore the cytological sample is often the only material available for diagnosis and assessment of molecular characteristics driving the treatment.